Anorexia Nervosa is a condition that usually affects young women and the condition can sometimes be fatal. Now researcher think it is due to
Anorexia Nervosa is a condition that usually affects young women and the condition can sometimes be fatal. Now researcher think it is due to overactive dopamine receptors in the basal ganglia region of the brain.
People with anorexia nervosa are driven to be excessively thin and are unaware of the seriousness of their condition.When you talk of Anorexia Nervosa, many will remember the death of the famous talented singer Karen Carpenter who died in the prime of her youth due to the condition. There are other famous personalities who also have suffered from the condition including Princess Diana. It is estimated that there maybe about 1% of women who suffer from the condition at some stage in their life.From the University of Pittsburgh a study has been reported in the journal Biological Psychiatry and it has found that the over-activity of dopamine receptors in the brain's basal ganglia. This area is known to play a role in how people learn from experience and make choices. The area maybe the culprit responsible for the condition.
The research may point to a molecular target for development of more effective treatments strategies than those currently available. The study used ‘Positron Emission Tomography (PET) imaging’ to assess the activity of brain dopamine receptors, a neurotransmitter system that is best known for its role in controlling movement.
The Dopamine receptors in the brain are usually associated with weight and feeding behaviors and responses to reinforcement and reward. Researchers used a harmless molecule designed to bind to the dopamine D2 and D3 receptors that lie on the membrane surface of neurons. Ten women who had recovered from anorexia nervosa for more than a year were studied, as were 12 normal female subjects. Because malnourishment affects brain chemistry, the researchers did not include acutely ill women in their study.
Since other studies have found reduced binding of these dopamine receptors in both people who are obese and those who have substance use problems, researchers Dr.Kaye and Frank hypothesized that they would find just the opposite in women with anorexia.
The researchers also found increased dopamine D2/D3 receptor activity in another part of the basal ganglia called the dorsal caudate, which is related to responses to and avoidance of harm. Such activity may help explain why women with anorexia exhibit exaggerated worry and concern about what might happen in the future.
Advertisement
"Taken together, the alterations in the dopamine system may help explain the tell-tale symptoms of anorexia," added Dr. Kaye.
Advertisement
"This finding may help us better understand brain dopamine function across a whole spectrum of disorders, with respect to its contribution to the avoidance of food and other stimuli in anorexia nervosa on one end, and the desire for stimuli, such as in food and drug use on the other," added Dr. Frank, a fellow in child psychiatry.
More research is needed to address the many questions that remain, including what causes the dopamine receptors to be overactive in the first place. Genetic studies could yield some answers. Indeed, a study supported by the Price Foundation, which was recently published in the online edition of Neuropsychopharmacology, found alterations in genes for the D2 receptor in some individuals with anorexia nervosa. Dr. Kaye is a co-author of that paper and principal investigator of the Price Foundation studies, including a new multi-center study that is now recruiting families with two or more members who have or had anorexia nervosa to help identify the genes that contribute to the eating disorder.
In addition to Drs. Kaye and Frank, other authors include Carolyn C. Meltzer, M.D., Julie C. Price, Ph.D., Chester A. Mathis, Ph.D., Jessica Hoge and Scott Ziolko, all of the University of Pittsburgh School of Medicine department of radiology; Ursula F. Bailer, M.D., Shannon E. Henry and Angela Wagner, M.D., from the University of Pittsburgh School of Medicine department of medicine; Lisa Weissfeld, Ph.D., from the University of Pittsburgh Graduate School of Public Health department of biostatistics; Wayne Drevits, M.D., from the National Institute of Mental Health; and Nicole Barbarich-Marsteller from the State University of New York at Stony Brook. The research was supported by the National Institute of Mental Health (NIMH) and the Price Foundation. More information about the multi-center study funded by the NIMH can be found at www.angenetics.org.
Contact: Lisa Rossi
[email protected]
Phone: 412-647-3555
Fax: 412-624-3184
Jocelyn Uhl
[email protected]
Phone: 412-647-3555
Fax: 412-624-3184
Source of News Extract: Eureka Alert